{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "SLNO",
    "data": {
        "bs": [
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 29978000
            },
            {
                "label": "Common stock, $0.001 par value, 250,000,000 shares authorized, 120,088,816 and 79,864,310 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 16085000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -219079000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -219100000.0
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 28974000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 29000000.0
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 42546000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 7313000
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 26461000
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 26461000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 350000
            },
            {
                "label": "Other long-term assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 40000
            },
            {
                "label": "Contingent liability for Essentialis purchase price",
                "concept": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent",
                "unit": "usd",
                "value": 8689000
            },
            {
                "label": "Commitments and contingencies (Note 6)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 27000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 12151000
            },
            {
                "label": "Additional paid-in-capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 245422000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1004000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 2411000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 344000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Long-term lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 79000
            },
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 439000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 598000
            },
            {
                "label": "Accrued clinical trial site costs",
                "concept": "slno:AccruedClinicalTrialCostsCurrent",
                "unit": "usd",
                "value": 3521000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 42546000
            }
        ],
        "cf": [
            {
                "label": "Accrued clinical trial site costs",
                "concept": "slno:IncreaseDecreaseInAccruedClinicalTrialSiteCosts",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Tax withholding payments for net share-settled equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 16000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -858000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -858000
            },
            {
                "label": "Non-cash lease expense",
                "concept": "slno:NoncashLeaseExpense",
                "unit": "usd",
                "value": 71000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 492000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "slno:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -34000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 7670000
            },
            {
                "label": "Net cash provided by (used in) financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 14032000
            },
            {
                "label": "Proceeds from sale of common stock and pre-funded warrants, net of costs",
                "concept": "slno:ProceedsFromSaleOfCommonStockAndPreFundedWarrantsNetOfCosts",
                "unit": "usd",
                "value": 14048000
            },
            {
                "label": "Unpaid costs for issuing common stock and pre-funded warrants",
                "concept": "slno:UnpaidCostsForIssuingCommonStockAndPreFundedWarrants",
                "unit": "usd",
                "value": 282000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -6362000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -6400000.0
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -130000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5724000
            },
            {
                "label": "Other non-cash reconciling items",
                "concept": "slno:OtherNonCashReconcilingItems",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Prepaid expenses, other current assets and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -114000
            },
            {
                "label": "Change in fair value of stock warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -27000
            },
            {
                "label": "Change in fair value of stock warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -27000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 644000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 37000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1046000
            }
        ],
        "ic": [
            {
                "label": "Net loss per common share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.07
            },
            {
                "label": "Total other income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 49000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -858000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -858000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3988000
            },
            {
                "label": "Total comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -5726000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5724000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5724000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5700000.0
            },
            {
                "label": "Interest income",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 22000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -5773000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 5773000
            },
            {
                "label": "Change in fair value of warrants liabilities",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -27000
            },
            {
                "label": "Change in fair value of warrants liabilities",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -27000
            },
            {
                "label": "Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 80020677
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2643000
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -2000
            }
        ]
    }
}